{"id":"W2790816436","doi":"10.1016/s0140-6736(18)30475-6","title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":925,"is_retracted":false,"has_abstract":false,"ca_institutions":"NeuroRx Research (Canada); McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Expanded Disability Status Scale; Clinical endpoint; Multiple sclerosis; Internal medicine; Clinical trial; Randomized controlled trial; Physical therapy; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002679878,0.002453706,0.005973777,0.0009060398,0.0007642676,0.001170309,0.001286502,0.002974225,0.009079578],"category_scores_gemma":[0.002129854,0.00105262,0.003454976,0.0006617864,0.002099329,0.001755102,0.0006714032,0.003503487,0.001259874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006289006,"about_ca_system_score_gemma":0.001482855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001275329,"about_ca_topic_score_gemma":0.002399662,"domain_scores_codex":[0.9990968,0.0004536327,0.00006911306,0.0001349624,0.0001004257,0.0001451372],"domain_scores_gemma":[0.998539,0.0006147434,0.0002449197,0.000135159,0.00008865803,0.000377496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9848733,0.003905869,0.0001050786,0.0007190665,0.0005021403,0.00003174512,0.00005118086,0.0001259316,0.002100931,0.00007397295,0.0003100999,0.007200663],"study_design_scores_gemma":[0.9545325,0.04411282,0.000516495,0.00002517693,0.0002404681,0.00001526994,0.00001408572,0.00009880903,0.0001719379,0.00007376961,0.0001887252,0.00001000664],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786043,0.008291417,0.001085175,0.0006377732,0.0008184669,0.006499312,0.001319976,0.000255504,0.002488156],"genre_scores_gemma":[0.9682349,0.00709221,0.003483862,0.001703828,0.001273117,0.01059695,0.001194385,0.00006954997,0.00635125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009079578,"threshold_uncertainty_score":0.03037423,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2042846764689597,"score_gpt":0.4062930836065874,"score_spread":0.2020084071376277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}